{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-178092","form_type":"8-K","ticker":"ASMB","cik":"0001426800","company_name":"ASSEMBLY BIOSCIENCES, INC.","filed_at":"2025-08-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.965428+00:00","generated_at":"2026-05-17T15:20:11.149778+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Assembly Bio prices $175M equity financing; net proceeds ~$167M","bullets":["Underwritten offering: 5.6M shares + 1.04M pre-funded warrants at $19.60/unit; net ~$122M.","Gilead purchases 2.3M shares + warrants in private placement at same price; net ~$45M.","Class A warrants exercisable at $21.60, expire 5 years from issuance or 30 days after Phase 2 enrollment announcement.","Class B warrants exercisable after Nov 15, 2026 until Dec 31, 2026; terminate early if $75M non-dilutive collaboration capital received.","Proceeds for general corporate purposes; closings on August 11, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-178092","json":"https://secwatch.observer/filing/0001193125-25-178092.json","markdown":"https://secwatch.observer/filing/0001193125-25-178092.md","text":"https://secwatch.observer/filing/0001193125-25-178092.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1426800/000119312525178092/0001193125-25-178092-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1426800/000119312525178092/d442009d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T15:20:11.149778+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}